Mednet Logo

Does the presence and location of cerebral microbleeds affect your decision for antithrombotic treatment in patients with atrial fibrillation?

Do you distinguish between primary and secondary prevention? Wilson et al., PMID 31130428 is helpful, but curious how people apply this data in practice.
3 Answers
Mednet Member
Mednet MemberInvited Expert
Neurology · Brown University Medical School
Answered on

That is a great question. Agree, the data is observational and no firm conclusions can be made. My practice is to consider left atrial appendage occlusion in patients with suspected CAA. In patients with hypertensive microbleeds, both resuming anticoagulation and left atrial appendage occlusion are ...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Neurology · Harvard Medical School
Answered on

As Dr. @Dr. First Last already said, even the large meta-analysis by Wilson et al., PMID 31130428 is based on observational data. Thus it is difficult to make hard, all-encompassing recommendations based on it.

To make matters more complicated, emerging evidence suggests that although deep CMBs/ICH ...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · Vanderbilt University Medical Center
Answered on

I would avoid anticoagulation in the presence of more than 10 microbleeds and would seek an electrophysiology solution or ligation of the atrial appendage with WATCHMAN.

Join for free or sign in to see the full answer